Genomic DNA was extracted from 5 mL of peripheral whole-venous blood using a salting out procedure, as previously described [24 (
link)], and quantified by
NanoDrop 2000 (Thermo Fisher Scientific, Inc., Waltham, MA, USA). T399I polymorphism (+1196C/T transition; rs4986791) was typed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Briefly, the DNA region comprehending the polymorphism was amplified by PCR by using the TLR4 T399I-forward: 5′-GGTTGCTGTTCTCAAAGTGATTTTGGGAGAA-3′ and TLR4 T399I-reverse: 5′-ACCTGAAGACTGGAGAGTGAGTTAAATGCT-3′ primers. Amplifications were carried out in a final volume of 30 μL including 200 ng of DNA template, primers at 500 nM and 1 U of
Taq polymerase (Invitrogen, Carlsbad, CA, USA). PCR conditions were as follows: denaturation for 4 min at 95 °C, 35 cycles of 45 sec at 95 °C, 45 sec at 67 °C and 90 sec at 72 °C, followed by 5 min at 72 °C. The specific amplificated band of 406 bp was digested by a
HinfI enzyme (New England Biolabs, Ipswich, MA, USA), following the manufacturer’s instructions. PCR-RFLP products were separated upon digestion in 3%
NuSieve GTG agarose gels (Lonza Rockland, Rockland, ME, USA) with
GelRed Nucleic Acid Gel Stain (Biotium, Fremont, CA, USA) and visualized under Ultraviolet (UV) light by using a ChemiDoc XRS analyzer (Bio-Rad, Hercules, CA, USA).
Marchionni E., Porpora M.G., Megiorni F., Piacenti I., Giovannetti A., Marchese C., Benedetti Panici P, & Pizzuti A. (2020). TLR4 T399I Polymorphism and Endometriosis in a Cohort of Italian Women. Diagnostics, 10(5), 255.